SCHEMBL3270582

SCHEMBL3270582

CCN(C)CC1(c2ccc(OCCCN3CCSCC3)cc2)CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPK1 P28482 2/20 0.49
CYP1A2 P05177 1/20 0.49
CHRM2 P08172 1/20 0.49
CHRM1 P11229 1/20 0.49
HTR2A P28223 1/20 0.49
SCN1A P35498 1/20 0.49
HTR2B P41595 1/20 0.49
KCNH2 Q12809 1/20 0.49
SCN2A Q99250 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
SCN3A Q9NY46 1/20 0.49
LMNA P02545 2/20 0.48
USP2 O75604 1/20 0.48
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
HRH2 P25021 1/20 0.39
HRH1 P35367 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3278664 0.91 HRH3 (0.50) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3272058 0.91 HRH3 (0.52) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3272344 0.91 HRH3 (0.60) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3274853 0.85 HRH3 (0.51) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3277078 0.83 HRH3 (0.55) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3273066 0.82 HRH3 (0.50) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3272967 0.82 HRH3 (0.54) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3277511 0.82 HRH3 (0.57) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3270444 0.82 HRH3 (0.60) HRH3ALDH1A1MAPK1CYP1A2CHRM2
SCHEMBL3271278 0.81 HRH3 (0.61) HRH3ALDH1A1MAPK1CYP1A2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050267095-A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands ZIARCO INC. 2005-12-01 US claimed
EP-1747210-B1 3- OR 4-MONOSUBSTITUTED PHENOL AND THIOPHENOL DERIVATIVES USEFUL AS H3 LIGANDS WARNER LAMBERT CO (US) 2010-06-30 EP disclosed
US-7456164-B2 Useful for treatment of H3-related diseases such as neurologic disorders, or inflammatory, respiratory and allergic diseases, disorders and conditions; for example, 4-[4-(1-isopropylpiperidin-4-yloxy)phenyl]tetrahydropyran-4-carbonitrile; well absorbed from gastrointestinal tract, metabolically stable PFIZER, INC (US) 2008-11-25 US disclosed
US-20050267095-A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands ZIARCO INC. 2005-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267095-A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as H3 ligands HRH4, HRH3, TLR4 HRH3 2/4885ALDH1A1 832/4885MAPK1 2421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.